FDA Adverse Event Injury Summary report: N

CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS

MDR report key: 3980462 · Received August 5, 2014

Report

Report Number
2015691-2014-01784
Event Type
Injury
Date Received
August 5, 2014
Date of Event
June 26, 2014
Report Date
July 7, 2014
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
P860057/S022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE EXPLANTED DEVICE WAS NOT RETURNED TO MANUFACTURER. WITHOUT RECEIPT OF THE REPORTED DEVICE, THE REPORTED CLINICAL OBSERVATION CANNOT BE CONFIRMED. EDWARDS WILL CONTINUE TO REVIEW AND MONITOR ALL EVENTS.

Description of Event or Problem · 1

EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL "CUSTOMER COMPLAINT". THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE. EDWARDS RECEIVED INFORMATION THAT A 21MM BIOPROSTHETIC AORTIC VALVE, IMPLANTED APPROXIMATELY NINE (9) YEARS AND ONE (1) MONTH, WAS EXPLANTED DUE TO REGURGITATION SECONDARY TO CALCIFICATION. THE EXPLANTED DEVICE WAS REPLACED WITH ANOTHER BIOPROSTHETIC VALVE. EXPLANTED DEVICE WAS NOT AVAILABLE FOR EVALUATION AS IT WAS DISCARDED AT HOSPITAL. THERE ARE NO ADVERSE EVENTS REPORTED FOLLOWING PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
456894 CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES 3000TFX

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| L| R